Spread the news

EU's medicine regulator said it would carry out a speedy evaluation. — Reuters pic
EU’s medicine regulator said it would carry out a speedy evaluation. — Reuters pic

Follow us on Instagram and subscribe to our Telegram channel for the latest updates.


SINGAPORE, Sept 6 — Europe’s medicines regulator said today it was evaluating data on a booster dose for the Covid-19 vaccine developed by Pfizer/BioNTech , to be given six months after the second dose in people aged 16 years and older.

The European Medicines Agency said it would carry out a speedy evaluation of the data, with an outcome expected “within the next few weeks”. It also added that it was also assessing data on the use of an additional dose of mRNA vaccines in people with weak immune systems. — Reuters

Click to rate this post!
[Total: 0 Average: 0]

Spread the news
CONTACT US : support@melodyinter.com
Previous articleAmunike eyes fresh challenge in coaching insists passion  intact
Next articleAfter Twitter labeled Serbian pro-government media: It is important to know who controls and exercises pressure on media

LEAVE A REPLY

Please enter your comment!
Please enter your name here